XML 51 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions and Joint Venture - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 01, 2022
Apr. 06, 2022
Mar. 31, 2022
Apr. 30, 2023
Jul. 31, 2023
Jul. 31, 2022
Oct. 31, 2022
Jan. 19, 2021
Business Acquisition [Line Items]                
Goodwill         $ 3,683,100,000   $ 3,609,700,000  
Accrual for acquisition termination fee         45,000,000.0 $ 0    
Proceeds from sale of interest in a subsidiary     $ 52,100,000   0 52,100,000    
Payments to form joint venture     10,000,000          
Equity method investments     $ 90,000,000          
Equity method investment realized gain             56,900,000  
Decrease in contingent consideration liability         31,800,000 $ 10,700,000    
SightGlass Vision, Inc.                
Business Acquisition [Line Items]                
Equity method investment, ownership percentage     50.00%          
Essilor International SAS                
Business Acquisition [Line Items]                
Payments to form joint venture     $ 10,000,000          
Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products                
Business Acquisition [Line Items]                
Aggregate consideration $ 33,000,000              
Net assets 5,100,000              
Goodwill 7,700,000              
Goodwill, expected tax deductible amount 0              
Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products | Customer relationships                
Business Acquisition [Line Items]                
Finite-lived intangibles 12,600,000              
Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products | Technology                
Business Acquisition [Line Items]                
Finite-lived intangibles $ 7,600,000              
Cook Medicals Reproductive Health Business                
Business Acquisition [Line Items]                
Aggregate consideration   $ 875,000,000            
Payments to acquire business   675,000,000            
Payables incurred in acquisition   200,000,000            
Accrual for acquisition termination fee       $ 45,000,000        
Cook Medicals Reproductive Health Business | Payables First Installment                
Business Acquisition [Line Items]                
Payables incurred in acquisition   50,000,000            
Cook Medicals Reproductive Health Business | Payables Second Installment                
Business Acquisition [Line Items]                
Payables incurred in acquisition   50,000,000            
Cook Medicals Reproductive Health Business | Payables Third Installment                
Business Acquisition [Line Items]                
Payables incurred in acquisition   50,000,000            
Cook Medicals Reproductive Health Business | Payables Fourth Installment                
Business Acquisition [Line Items]                
Payables incurred in acquisition   $ 50,000,000            
Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners                
Business Acquisition [Line Items]                
Undiscounted range of the contingent consideration, minimum               $ 0
Undiscounted range of the contingent consideration, maximum               $ 139,100,000
Payment to settle former equity interest owners     $ 42,900,000          
Net gains recognized             $ 12,200,000  
Decrease in contingent consideration liability         $ 31,800,000